Global Calcium Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DIBASIC SODIUM PHOSPHATE USP, with a corresponding US DMF Number 38073.
Remarkably, this DMF maintains an Active status since its submission on April 13, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 28, 2023, and payment made on November 24, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II